Shanghai Zhixin Medical Supply Chain Management Co., Ltd. signed a Share Transfer agreement to acquire Dale (Fujian) Healthcare Co., Ltd. from Shanghai C & D Co., Ltd. and Xiamen C&D Inc. (SHSE:600153) for approximately CNY 340 million on April 23, 2021. Xiamen C&D will transfer 95% and Shanghai C & D Co., Ltd. will transfer 5%. For the year ended December 31, 2020, Dale (Fujian) Healthcare reported Total Assets as CNY 674.5 million , Revenue as CNY 1.3 billion and Net income as CNY 48.2 million